BELLOMO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 829
SA - Sud America 334
NA - Nord America 149
EU - Europa 131
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.464
Nazione #
BR - Brasile 276
HK - Hong Kong 228
SG - Singapore 213
VN - Vietnam 166
US - Stati Uniti d'America 127
CN - Cina 120
DE - Germania 54
IT - Italia 36
KR - Corea 32
ID - Indonesia 22
AR - Argentina 18
FR - Francia 16
IN - India 15
MX - Messico 15
EC - Ecuador 14
BD - Bangladesh 7
CO - Colombia 7
CL - Cile 6
PH - Filippine 5
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
RU - Federazione Russa 4
UA - Ucraina 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
CA - Canada 3
MA - Marocco 3
UY - Uruguay 3
VE - Venezuela 3
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GB - Regno Unito 2
IQ - Iraq 2
JM - Giamaica 2
NL - Olanda 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
SE - Svezia 2
TN - Tunisia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.464
Città #
Hong Kong 228
Ho Chi Minh City 61
Frankfurt am Main 52
Ashburn 37
Hanoi 34
Seoul 32
Singapore 32
San Jose 31
Beijing 27
São Paulo 16
Chicago 12
Haiphong 9
Brasília 8
Guayaquil 7
Rio de Janeiro 7
Rome 7
Dallas 6
Mexico City 6
Porto Alegre 6
Salvador 6
Campinas 5
Da Nang 5
New York 5
Thái Bình 5
Belo Horizonte 4
Chennai 4
Council Bluffs 4
Duque de Caxias 4
Jundiaí 4
Los Angeles 4
Manaus 4
Nairobi 4
Ninh Bình 4
Ribeirão Preto 4
Thái Nguyên 4
Bauru 3
Bengaluru 3
Bogotá 3
Bắc Ninh 3
Can Tho 3
Curitiba 3
Hải Dương 3
Jakarta 3
Lima 3
Mauá 3
Orem 3
Piracicaba 3
Quito 3
Reston 3
Santo André 3
Uberlândia 3
Varginha 3
Addis Ababa 2
Alvorada 2
Americana 2
Aracaju 2
Arlington 2
Baku 2
Belém 2
Biên Hòa 2
Buenos Aires 2
Cabo Frio 2
Cariacica 2
Colombo 2
Esmeraldas 2
Florence 2
Formosa 2
Fortaleza 2
Goiânia 2
Guarulhos 2
Hưng Yên 2
Indaiatuba 2
Itaquaquecetuba 2
João Pessoa 2
Maceió 2
Miami 2
Milan 2
Montevideo 2
Mumbai 2
Muscat 2
Osasco 2
Palhoça 2
Paulistana 2
Perugia 2
Quixadá 2
Recanati 2
Recife 2
Rio das Ostras 2
Santa Clara 2
Santiago 2
Sousse 2
Surabaya 2
Suzano 2
São Gonçalo 2
Trieste 2
Tây Ninh 2
Warsaw 2
Wroclaw 2
Acopiara 1
Agadir 1
Totale 833
Nome #
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 156
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 76
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 60
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 58
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 52
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 43
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? 38
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 36
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 35
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 33
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: Relevance for α-synuclein measurement 33
Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study 33
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 32
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias 32
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 30
Unlocking the full clinical potential of the α-synuclein seed amplification assay 29
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 28
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 28
Revisiting paramagnetic relaxation enhancements in slowly rotating systems: how long is the long range? 28
Parkinson's and Lewy body dementia CSF biomarkers 27
The National Italian Guidelines on the diagnosis and treatment of children with pediatric ataxias 27
MULTIFREQUENCY BIOIMPEDENTIOMETER 27
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 26
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 26
Aquaporin-4 as an early cerebrospinal fluid biomarker of Alzheimer’s disease 25
Quantification of SPECT Concentric Ring Artifacts by Radiomics and Radial Features 25
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 25
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 25
Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors 24
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 24
Seed amplification assays for diagnosing synucleinopathies: The issue of influencing factors 24
Aggregation kinetics of the Aβ1-40 peptide monitored by NMR 24
Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease 23
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 23
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 23
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 23
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 23
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 22
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 22
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 22
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 22
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 21
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 19
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 18
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 18
Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias 18
Multivariate Curve Resolution for 2D Solid-State NMR spectra 17
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 14
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 1
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 1
Totale 1.519
Categoria #
all - tutte 5.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025313 0 0 0 0 1 3 7 4 1 245 42 10
2025/20261.206 88 31 246 344 132 33 34 87 92 119 0 0
Totale 1.519